Skip to main content
TipRanks
Go Ultimate75% OFF

NeonMind Biosciences Inc (LCR) Financial Statements

15 Followers

NeonMind Biosciences Inc Financial Overview

NeonMind Biosciences Inc's market cap is currently C$1.09M. The company's EPS TTM is C$-0.01; its P/E ratio is -0.88; NeonMind Biosciences Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 25Jun 24Mar 24Feb 23Feb 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -1.33MC$ -1.06M―C$ -1.75MC$ -7.83M
EBITDAC$ -1.58MC$ 403.40K―C$ -1.75MC$ -7.83M
Net IncomeC$ -1.75MC$ -1.54M―C$ -2.03MC$ -7.21M
Balance Sheet
Cash & Short-Term InvestmentsC$ 206.03KC$ 13.98KC$ 135.40KC$ 69.91KC$ 967.27K
Total AssetsC$ 1.09MC$ 91.12KC$ 719.33KC$ 129.43KC$ 1.34M
Total DebtC$ 1.14MC$ 1.19MC$ 1.04MC$ 846.94KC$ 450.01K
Net DebtC$ 963.54KC$ 1.19MC$ 984.93KC$ 811.12KC$ -323.52K
Total LiabilitiesC$ 1.74MC$ 2.00MC$ 1.33MC$ 1.53MC$ 1.05M
Stockholders' EquityC$ -635.18KC$ -1.90MC$ -612.89KC$ -1.40MC$ 290.30K
Cash Flow
Free Cash FlowC$ -988.65KC$ -89.79KC$ -1.31MC$ -1.22MC$ -5.82M
Operating Cash FlowC$ -988.66KC$ -89.79KC$ -1.13MC$ -1.08MC$ -5.82M
Investing Cash FlowC$ -129.42KC$ 37.60KC$ -36.15KC$ 72.14KC$ 389.12K
Financing Cash FlowC$ 1.29MC$ 0.00C$ 627.93KC$ 271.00KC$ 6.20M

Currency in CAD

NeonMind Biosciences Inc Earnings and Revenue History

-8M-4M04M-645 %-644 %-643 %-642 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin

NeonMind Biosciences Inc Liabilities to Assets

0800K1.6M2.4M0 %800 %1600 %2400 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets

NeonMind Biosciences Inc Cash Flow

-7.5M-5M-2.5M02.5M5M7.5M202020212022202320242025OperatingInvestingFinancing

NeonMind Biosciences Inc Forecast EPS vs Actual EPS

000000Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27EPS EstimateBeatMiss